Graciane Laender Moreira1, Beatriz Martins Manzano1, Mariana Rodrigues Gazzotti2, Oliver Augusto Nascimento3, Rogelio Perez-Padilla4, Ana Maria Baptista Menezes5, José Roberto Jardim6. 1. Federal University of São Paulo, São Paulo, Brazil, Physiotherapist. Federal University of São Paulo, São Paulo, Brazil. 2. São Camilo University Center, Department of Physical Therapy, São Paulo, Brazil, Professor. Department of Physical Therapy, São Camilo University Center, São Paulo, Brazil. 3. Federal University of São Paulo, Department of Pulmonology, São Paulo, Brazil, Attending Physician, Department of Pulmonology, Federal University of São Paulo, São Paulo, Brazil. 4. Instituto Nacional de Enfermedades Respiratórias, Mexico City, Mexico, Professor. Instituto Nacional de Enfermedades Respiratórias, Mexico City, Mexico. 5. Federal University of Pelotas, School of Medicine, Department of Clinical Medicine, Pelotas, Brazil, Full Professor of Pulmonology. Department of Clinical Medicine, Federal University of Pelotas School of Medicine, Pelotas, Brazil. 6. Federal University of São Paulo, Department of Pulmonology, São Paulo, Brazil, Tenured Professor. Department of Pulmonology, Federal University of São Paulo, São Paulo, Brazil.
Abstract
OBJECTIVE: To determine the underdiagnosis rate in new COPD cases at the end of a nine-year follow-up period-in the study designated "Projeto Latino-Americano de Investigação em Obstrução Pulmonar" (PLATINO, Latin-American Pulmonary Obstruction Investigation Project)-and compare that with the underdiagnosis rate during the initial phase of the study, as well as to identify the clinical features exhibited by the subjects who were not diagnosed until the end of the follow-up phase. METHODS: The study population comprised the 1,000 residents of the city of São Paulo, Brazil, who took part in the PLATINO study. Of those, 613 participated in the follow-up phase, during which the subjects were assessed with the same instruments and equipment employed in the initial phase of the study. We used the chi-square test or the independent sample t-test to analyze the underdiagnosis rate and to identify the characteristics of the subjects who were not diagnosed until the end of the follow-up phase. RESULTS: The underdiagnosis rate for new COPD cases at the end of the nine-year follow-up period was 70.0%. The underdiagnosis rate during the follow-up phase was 17.5% lower than that reported for the initial phase of the study. The subjects who were not diagnosed until the end of the follow-up phase presented with fewer respiratory symptoms, better pulmonary function, and less severe disease than did those previously diagnosed with COPD. CONCLUSIONS: The underdiagnosis rate for new COPD cases was lower in the follow-up phase of the study than in the initial phase. The subjects who were not diagnosed until the end of the follow-up phase of the PLATINO study presented with the same clinical profile as did those who were not diagnosed in the initial phase. These findings underscore the need for spirometry in order to confirm the diagnosis of COPD and provide early intervention.
OBJECTIVE: To determine the underdiagnosis rate in new COPD cases at the end of a nine-year follow-up period-in the study designated "Projeto Latino-Americano de Investigação em Obstrução Pulmonar" (PLATINO, Latin-American Pulmonary Obstruction Investigation Project)-and compare that with the underdiagnosis rate during the initial phase of the study, as well as to identify the clinical features exhibited by the subjects who were not diagnosed until the end of the follow-up phase. METHODS: The study population comprised the 1,000 residents of the city of São Paulo, Brazil, who took part in the PLATINO study. Of those, 613 participated in the follow-up phase, during which the subjects were assessed with the same instruments and equipment employed in the initial phase of the study. We used the chi-square test or the independent sample t-test to analyze the underdiagnosis rate and to identify the characteristics of the subjects who were not diagnosed until the end of the follow-up phase. RESULTS: The underdiagnosis rate for new COPD cases at the end of the nine-year follow-up period was 70.0%. The underdiagnosis rate during the follow-up phase was 17.5% lower than that reported for the initial phase of the study. The subjects who were not diagnosed until the end of the follow-up phase presented with fewer respiratory symptoms, better pulmonary function, and less severe disease than did those previously diagnosed with COPD. CONCLUSIONS: The underdiagnosis rate for new COPD cases was lower in the follow-up phase of the study than in the initial phase. The subjects who were not diagnosed until the end of the follow-up phase of the PLATINO study presented with the same clinical profile as did those who were not diagnosed in the initial phase. These findings underscore the need for spirometry in order to confirm the diagnosis of COPD and provide early intervention.
Authors: Kylie Hill; Roger S Goldstein; Gordon H Guyatt; Maria Blouin; Wan C Tan; Lori L Davis; Diane M Heels-Ansdell; Marko Erak; Pauline J Bragaglia; Itamar E Tamari; Richard Hodder; Matthew B Stanbrook Journal: CMAJ Date: 2010-04-06 Impact factor: 8.262
Authors: Ana Maria B Menezes; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Maria Montes de Oca; Carlos Talamo; Pedro C Hallal; Cesar G Victora Journal: Lancet Date: 2005-11-26 Impact factor: 79.321
Authors: O A Nascimento; A Camelier; F W Rosa; A M B Menezes; R Pérez-Padilla; J R Jardim Journal: Braz J Med Biol Res Date: 2007-07 Impact factor: 2.590
Authors: Maria Montes de Oca; Carlos Tálamo; Ronald J Halbert; Rogelio Perez-Padilla; Maria Victorina Lopez; Adriana Muiño; José Roberto B Jardim; Gonzalo Valdivia; Julio Pertuzé; Dolores Moreno; Ana Maria B Menezes Journal: Respir Med Date: 2009-04-11 Impact factor: 3.415
Authors: Rogelio Perez-Padilla; Fernando C Wehrmeister; Bartolome R Celli; Maria Victorina Lopez-Varela; Maria Montes de Oca; Adriana Muiño; Carlos Talamo; Jose R Jardim; Gonzalo Valdivia; Carmen Lisboa; Ana Maria B Menezes Journal: PLoS One Date: 2013-08-01 Impact factor: 3.240
Authors: Sonia Maria Martins; William Salibe-Filho; Luís Paulo Tonioli; Luís Eduardo Pfingesten; Patrícia Dias Braz; Juliet McDonnell; Siân Williams; Débora do Carmo; Jaime Correia de Sousa; Hilary Pinnock; Rafael Stelmach Journal: NPJ Prim Care Respir Med Date: 2016-08-18 Impact factor: 2.871
Authors: Ludmila Peres Gargano; Isabella de Figueiredo Zuppo; Mariana Martins Gonzaga do Nascimento; Valéria Maria Augusto; Brian Godman; Juliana de Oliveira Costa; Francisco Assis Acúrcio; Juliana Álvares-Teodoro; Augusto Afonso Guerra Journal: Front Big Data Date: 2022-02-07